Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Nov 6 · below the Ichimoku cloud · RSI 50 · MACD below its signal
None of the 29 investors followed here reported a position in MJNA in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MJNA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for MJNA.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 50.0 | -33.3 | -50.0 | 0.0 | 100.0 | 0.0 | -25.0 | −25.0% | ||
| 2025 | 0.0 | -25.0 | 0.0 | -16.7 | 20.0 | -16.7 | -20.0 | 50.0 | -33.3 | -50.0 | 0.0 | 100.0 | −50.0% |
| 2024 | -2.7 | -27.8 | 0.0 | 3.8 | -29.6 | -10.5 | -11.8 | -26.7 | 0.0 | -27.3 | -37.5 | -20.0 | −89.2% |
| 2023 | 24.6 | -38.2 | -8.5 | 7.0 | -19.6 | -10.8 | 0.0 | 36.4 | 44.4 | -41.5 | 23.7 | -21.3 | −39.3% |
| 2022 | -8.7 | 0.0 | 44.6 | -28.4 | -7.5 | -18.6 | 4.6 | -0.7 | -17.6 | 14.3 | -18.0 | -41.9 | −66.8% |
| 2021 | 54.7 | 178.0 | -29.9 | -6.5 | -19.6 | -20.0 | -5.2 | -1.5 | -15.7 | -14.1 | 4.5 | -20.0 | +2.8% |
| 2020 | 1.4 | -26.9 | -1.9 | -5.9 | 74.8 | -34.4 | -8.5 | 12.0 | -18.2 | 0.4 | 51.1 | -14.1 | −14.4% |
| 2019 | 6.0 | -11.0 | -13.5 | -14.9 | 26.0 | -17.9 | -17.7 | -5.7 | -20.6 | -27.5 | 5.8 | -17.7 | −72.0% |
| 2018 | -25.2 | -10.5 | -7.2 | 16.8 | -1.5 | -6.2 | -11.5 | 14.7 | -11.8 | -7.9 | -15.0 | 6.0 | −50.1% |
| 2017 | -23.6 | -30.1 | 20.5 | -8.7 | -10.9 | 0.4 | 6.2 | -16.5 | -9.8 | -7.4 | 23.6 | 55.1 | −25.5% |
| 2016 | -11.4 | 5.2 | 1.2 | 10.3 | 17.7 | -11.3 | 8.2 | 0.5 | 24.5 | 155.1 | -15.8 | 72.1 | +443.2% |
| 2015 | 6.3 | -8.3 | -14.0 | -15.3 | -2.5 | -11.3 | -28.9 | -18.1 | -31.4 | 10.7 | 58.7 | -24.8 | −67.5% |
| 2014 | 137.0 | -18.9 | -4.4 | -34.4 | 5.9 | -0.2 | -8.8 | -11.6 | -28.5 | 49.1 | -16.2 | -20.1 | −26.5% |
| 2013 | 121.8 | 42.9 | -21.7 | -25.0 | -19.6 | -8.7 | -10.8 | 28.4 | -11.3 | 0.0 | -16.4 | 32.5 | +53.5% |
| 2012 | 51.5 | 188.0 | -20.8 | -38.6 | 14.3 | -35.2 | 6.2 | 81.8 | 10.0 | 145.5 | -40.6 | 25.9 | +512.1% |
| 2011 | 29.3 | -30.4 | 400.0 | 3.3 | -43.5 | -38.1 | -12.3 | -19.3 | -32.6 | -3.2 | -40.3 | -7.8 | −58.7% |
| 2010 | 17.0 | -11.8 | -34.3 | -42.4 | −61.0% |
No analyst coverage for this instrument.
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, California.
No recent headlines.